A team of researchers, led by A/Prof Gautam Sethi from N2CR, conducted a study investigating the therapeutic possibilities of berberine, a natural compound, for breast cancer. Their findings revealed that berberine has the ability to effectively hinder the growth and metastasis of breast cancer cells in an environment with low oxygen levels. Additionally, the researchers observed that berberine can modify the gut microbiome and regulate specific molecules within the body. The study presents compelling evidence supporting berberine’s potential as an anti-cancer agent in combating breast carcinoma and holds great promise as a potential treatment option for breast cancer.
Read more: https://www.sciencedirect.com/science/article/pii/S1043661823001731?via%3Dihub
